MXPA03009023A - Composiciones veterinarias que comprenden derivados de oximaavermectina y praziquantel. - Google Patents

Composiciones veterinarias que comprenden derivados de oximaavermectina y praziquantel.

Info

Publication number
MXPA03009023A
MXPA03009023A MXPA03009023A MXPA03009023A MXPA03009023A MX PA03009023 A MXPA03009023 A MX PA03009023A MX PA03009023 A MXPA03009023 A MX PA03009023A MX PA03009023 A MXPA03009023 A MX PA03009023A MX PA03009023 A MXPA03009023 A MX PA03009023A
Authority
MX
Mexico
Prior art keywords
praziquantel
avermectin
veterinary compositions
oxime derivatives
oxime
Prior art date
Application number
MXPA03009023A
Other languages
English (en)
Inventor
Bernard Frank Bishop
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MXPA03009023A publication Critical patent/MXPA03009023A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA03009023A 2001-04-04 2002-03-28 Composiciones veterinarias que comprenden derivados de oximaavermectina y praziquantel. MXPA03009023A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0108485.4A GB0108485D0 (en) 2001-04-04 2001-04-04 Combination therapy
PCT/IB2002/001025 WO2002094288A1 (en) 2001-04-04 2002-03-28 Veterinary compositions comprising avermectin-oxime derivatives and praziquantel

Publications (1)

Publication Number Publication Date
MXPA03009023A true MXPA03009023A (es) 2004-02-12

Family

ID=9912257

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03009023A MXPA03009023A (es) 2001-04-04 2002-03-28 Composiciones veterinarias que comprenden derivados de oximaavermectina y praziquantel.

Country Status (7)

Country Link
EP (1) EP1381374A1 (es)
JP (1) JP2004526804A (es)
BR (1) BR0208654A (es)
CA (1) CA2443068A1 (es)
GB (1) GB0108485D0 (es)
MX (1) MXPA03009023A (es)
WO (1) WO2002094288A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05010659A (es) * 2003-04-04 2005-12-12 Merial Ltd Formulaciones veterinarias antihelminticas topicas.
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
FR2936710B1 (fr) * 2008-10-07 2011-01-07 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
EP2408771B1 (en) 2009-03-17 2016-11-16 Concert Pharmaceuticals, Inc. Pyrazinoisoquinoline compounds
GB0905365D0 (en) 2009-03-27 2009-05-13 Norbrook Lab Ltd A topical parasiticide composition
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
JP5723567B2 (ja) * 2010-08-06 2015-05-27 丸石製薬株式会社 含窒素複素環式化合物の定量方法
MD20170008A2 (ro) 2012-02-06 2017-07-31 Merial Inc. Compoziţii veterinare antiparazitare orale cu conţinut de agenţi activi cu acţiune sistemică, metode şi aplicări ale acestora
EP2833866B1 (en) 2012-04-04 2018-11-21 Intervet International B.V. Soft chewable pharmaceutical products

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9300883D0 (en) * 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
BG61064B1 (bg) * 1993-08-12 1996-10-31 Илия Илиев Лекарствено средство за обезпаразитяване на животни
AUPM969994A0 (en) * 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
US6165987A (en) * 1996-07-30 2000-12-26 Harvey; Colin Manson Anthelmintic formulations
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations

Also Published As

Publication number Publication date
WO2002094288A1 (en) 2002-11-28
GB0108485D0 (en) 2001-05-23
CA2443068A1 (en) 2002-11-28
JP2004526804A (ja) 2004-09-02
BR0208654A (pt) 2004-03-09
EP1381374A1 (en) 2004-01-21

Similar Documents

Publication Publication Date Title
HUP0400467A3 (en) 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
IL158041A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
IL195166A0 (en) Interferons, uses and compositions related thereto
MXPA03007848A (es) Derivados de quinolil propil piperidina, su preparacion y las composiciones que los contienen.
HUP0500024A3 (en) 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them
ZA200302929B (en) Compositions comprising cyclohexamantane.
MXPA03008140A (es) Amidas de acido benzofuran-2-carboxilico sustituidas.
ZA200206779B (en) Solid formulation.
GB0408601D0 (en) Disengagable reamer
IL154240A0 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
HUP0303155A3 (en) 2-thio-substituted imidazole derivatives, the use thereof and pharmaceutical compositions containing them
MXPA03009023A (es) Composiciones veterinarias que comprenden derivados de oximaavermectina y praziquantel.
ZA200309513B (en) Novel heterocyclic derivatives and medicinal use thereof.
AU7816000A (en) Pediculocidal and veterinary compositions
EP1392317A4 (en) SUBSTITUTED 1-BENZAZEPINE AND DERIVATIVES THEREOF
PL374761A1 (en) N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
ZA200404807B (en) Imidazoquinoline derivatives.
HK1052168A1 (en) N-deacetylthiocolchincine derivatives and pharmaceutical compositions containing them.
MXPA03008394A (es) Derivados de biuretano.
HUP0401162A3 (en) Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives